JPS6332768B2 - - Google Patents

Info

Publication number
JPS6332768B2
JPS6332768B2 JP9214579A JP9214579A JPS6332768B2 JP S6332768 B2 JPS6332768 B2 JP S6332768B2 JP 9214579 A JP9214579 A JP 9214579A JP 9214579 A JP9214579 A JP 9214579A JP S6332768 B2 JPS6332768 B2 JP S6332768B2
Authority
JP
Japan
Prior art keywords
parts
weight
vaccine
virus
spga
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP9214579A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5519271A (en
Inventor
Jee Makuaree Uiriamu
Zetsuto Maakusu Henrii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS5519271A publication Critical patent/JPS5519271A/ja
Publication of JPS6332768B2 publication Critical patent/JPS6332768B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
JP9214579A 1978-07-21 1979-07-21 Herpes virus vaccine Granted JPS5519271A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92706978A 1978-07-21 1978-07-21

Publications (2)

Publication Number Publication Date
JPS5519271A JPS5519271A (en) 1980-02-09
JPS6332768B2 true JPS6332768B2 (enExample) 1988-07-01

Family

ID=25454121

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9214579A Granted JPS5519271A (en) 1978-07-21 1979-07-21 Herpes virus vaccine

Country Status (12)

Country Link
EP (1) EP0008255B1 (enExample)
JP (1) JPS5519271A (enExample)
AT (1) ATE3058T1 (enExample)
AU (1) AU532186B2 (enExample)
DE (1) DE2965191D1 (enExample)
DK (1) DK306379A (enExample)
ES (1) ES8107300A1 (enExample)
HU (1) HU182530B (enExample)
IE (1) IE48379B1 (enExample)
PL (1) PL217216A1 (enExample)
PT (1) PT69953A (enExample)
RO (1) RO76563A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808922D0 (en) * 1998-04-24 1998-06-24 Cantab Pharmaceuticals Res Ltd Virus preparations
FR2804026B1 (fr) 2000-01-21 2004-06-11 Merial Sas Vaccination contre l'herpesvirose canine et vaccins
EP2802649B1 (en) 2012-01-09 2017-08-09 Sanofi Pasteur Biologics, LLC Purification of herpes virus
US11260123B2 (en) 2012-05-21 2022-03-01 Sanofi Pasteur Limited Herpesvirus compositions and related methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US3981771A (en) * 1973-07-19 1976-09-21 Martin Sevoian Marek's disease vaccine
US3959466A (en) * 1974-04-15 1976-05-25 The Wistar Institute Highly attenuated cytomegalovirus vaccine and production thereof

Also Published As

Publication number Publication date
DE2965191D1 (en) 1983-05-19
EP0008255A1 (en) 1980-02-20
IE48379B1 (en) 1984-12-26
HU182530B (en) 1984-01-30
ES482549A0 (es) 1980-12-16
ES8107300A1 (es) 1980-12-16
RO76563A2 (ro) 1981-04-30
JPS5519271A (en) 1980-02-09
ATE3058T1 (de) 1983-04-15
PL217216A1 (enExample) 1980-12-15
PT69953A (en) 1979-08-01
EP0008255B1 (en) 1983-04-13
AU4882079A (en) 1980-01-24
DK306379A (da) 1980-01-22
AU532186B2 (en) 1983-09-22

Similar Documents

Publication Publication Date Title
AU748296B2 (en) Stabilizers for lyophilized vaccines
JP3898221B2 (ja) トレハロースを含む乾燥血液因子組成物
JP4841726B2 (ja) ヒトパピローマウイルスワクチン製剤
EP0130619B1 (en) Hepatitis b vaccine and method for its preparation
EP0295043B1 (en) Stabilized live attenuated vaccine and its production
US3783098A (en) Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
RU2484847C2 (ru) Лиофилизированный препарат, содержащий гриппозную вакцину, и способ его получения
JP2001503781A (ja) モノクローナル抗体又はポリクローナル抗体の安定な凍結乾燥された医薬製剤
US4317811A (en) Herpes simplex type 1 subunit vaccine
US6051238A (en) Stabilizers for lyophilized mumps vaccines
US5024836A (en) Stable lyophilized live herpes virus vaccine
AU725231B2 (en) Stabilisers for lyophilised vaccines
JPS6332768B2 (enExample)
EP0290197B1 (en) Stable lyophilized live herpes virus vaccine
CA1183083A (en) Herpes virus vaccine
KR830000229B1 (ko) 동결 건조된 세포유리 터어키 헬페스 바이러스의 안정한 조성물